Cargando…
Involvement of SNX1 in regulating EGFR endocytosis in a gefitinib-resistant NSCLC cell lines
The drug gefitinib, a specific inhibitor of EGFR tyrosine kinase, has been shown to suppress the activation of EGFR signaling for survival and cell proliferation in non-small cell lung cancer cell lines. For many years, EGFR endocytosis has served as a model for investigating ligand-induced, recepto...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992535/ https://www.ncbi.nlm.nih.gov/pubmed/35582586 http://dx.doi.org/10.20517/cdr.2019.15 |